Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension
Authors
Keywords
-
Journal
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
Volume 2023, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2023-06-22
DOI
10.1155/2023/7890188
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation
- (2022) Anthony J. Turner et al. PEPTIDES
- Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects
- (2022) Arash Y. Tehrani et al. Scientific Reports
- The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation
- (2021) Kandi Xu et al. Frontiers in Oncology
- The presence of underlying asthma should be investigated in patients diagnosed with ACE inhibitor induced cough
- (2020) İnsu Yılmaz et al. Clinical Respiratory Journal
- Role of angiotensin-converting enzyme in myeloid cell immune responses
- (2020) Duo-Yao Cao et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
- (2020) Fabian Sanchis-Gomar et al. MAYO CLINIC PROCEEDINGS
- Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
- (2019) Lauren B. Arendse et al. PHARMACOLOGICAL REVIEWS
- The effect of Aliskiren on exercise capacity in older patients with heart failure and preserved ejection fraction: A randomized, placebo-controlled, double-blind trial
- (2018) Bharathi Upadhya et al. AMERICAN HEART JOURNAL
- Severe beta blocker and calcium channel blocker overdose: Role of high dose insulin
- (2018) Karan Seegobin et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials
- (2018) Bernice Tsoi et al. Heart Lung and Circulation
- Treatment of Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
- (2018) R. Gentry Wilkerson et al. JOURNAL OF EMERGENCY MEDICINE
- Phenolic Compounds in Honey and Their Associated Health Benefits: A Review
- (2018) Danila Cianciosi et al. MOLECULES
- Antihypertensive drugs and risk of skin cancer
- (2018) Nicoletta Cassano et al. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA
- Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design
- (2018) Gyles E. Cozier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cochrane corner: beta-blockers for hypertension
- (2017) Charles S Wiysonge et al. HEART
- Effects of bioactive peptides encrypted in whey-, soy- and rice protein on local and systemic angiotensin-converting enzyme activity
- (2017) Lydia Michelke et al. Journal of Functional Foods
- Blood pressure variability and cardiovascular disease: systematic review and meta-analysis
- (2016) Sarah L Stevens et al. BMJ-British Medical Journal
- Blood pressure variability and cardiovascular disease: systematic review and meta-analysis
- (2016) Sarah L Stevens et al. BMJ-British Medical Journal
- Anti-hypertensive Herbs and their Mechanisms of Action: Part I
- (2016) Sara S. Al Disi et al. Frontiers in Pharmacology
- Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison
- (2015) Daniel Villela et al. CLINICAL SCIENCE
- Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
- (2015) Mil.osz Regulski et al. CURRENT PHARMACEUTICAL DESIGN
- ACE2 and Microbiota
- (2015) Colleen T. Cole-Jeffrey et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Use of antihypertensive drugs and risk of skin cancer
- (2015) S.A.J. Schmidt et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dietary Supplements in the Management of Hypertension and Diabetes - A Review
- (2014) AJ Afolayan et al. African Journal of Traditional Complementary and Alternative Medicines
- Updated National and International Hypertension Guidelines: A Review of Current Recommendations
- (2014) Sverre Kjeldsen et al. DRUGS
- Molecular Targets of Antihypertensive Peptides: Understanding the Mechanisms of Action Based on the Pathophysiology of Hypertension
- (2014) Kaustav Majumder et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multiple Functions of Angiotensin-Converting Enzyme 2 and Its Relevance in Cardiovascular Diseases
- (2013) Keiji Kuba et al. CIRCULATION JOURNAL
- Renin–Angiotensin System Blocking Drugs
- (2013) Nicolás Roberto Robles et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Clinical Practice Guidelines for the Management of Hypertension in the Community
- (2013) Michael A. Weber et al. Journal of Clinical Hypertension
- The insertion-deletion polymorphism of the ACE gene is associated with increased blood pressure in women at the end of pregnancy
- (2013) Evgeny A Reshetnikov et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Involvement of substance P and the NK-1 receptor in cancer progression
- (2013) Miguel Muñoz et al. PEPTIDES
- Three key proteases – angiotensin-I-converting enzyme (ACE), ACE2 and renin – within and beyond the renin-angiotensin system
- (2012) Cuie Guang et al. Archives of Cardiovascular Diseases
- Angiotensin-converting enzyme insertion/deletion polymorphism is a risk factor for thoracic aortic aneurysm in patients with bicuspid or tricuspid aortic valves
- (2012) Ilenia Foffa et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Real-life safety and effectiveness of amlodipine/valsartan combination in the treatment of hypertension
- (2011) Irina E. Chazova et al. ADVANCES IN THERAPY
- Meta-Analysis of Randomized Controlled Trials on Effect of Angiotensin-Converting Enzyme Inhibitors on Cancer Risk
- (2011) Ilke Sipahi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Calcium Channel Blockers
- (2011) William J. Elliott et al. Journal of Clinical Hypertension
- ACE I/D Gene Polymorphism Can't Predict the Steroid Responsiveness in Asian Children with Idiopathic Nephrotic Syndrome: A Meta-Analysis
- (2011) Tian-Biao Zhou et al. PLoS One
- Insertion/Deletion Polymorphism of the Angiotensin-Converting Enzyme Predicts Left Ventricular Hypertrophy After Renal Transplantation
- (2011) R. Fedor et al. TRANSPLANTATION PROCEEDINGS
- ACE2/ANG-(1–7)/Mas pathway in the brain: the axis of good
- (2010) Ping Xu et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Definition and Classification of Hypertension: An Update
- (2009) Thomas D. Giles et al. Journal of Clinical Hypertension
- Angiotensin inhibition and malignancies: a review
- (2009) T Rosenthal et al. JOURNAL OF HUMAN HYPERTENSION
- Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphic Variant as a Marker of Coronary Artery DiseaseA Meta-analysis
- (2008) Elias Zintzaras ARCHIVES OF INTERNAL MEDICINE
- Pharmacologic modulation of ACE2 expression
- (2008) María José Soler et al. CURRENT HYPERTENSION REPORTS
- β-blockers as fourth-line therapy for hypertension: stay the course
- (2008) S. Bangalore et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More